Last reviewed · How we verify
NCT03027908
A Study to Measure the Effect of Two Fluoride Toothpastes on Gingival Health Over a Six Month Period
NA trial testing Fluoride Toothpaste 1 in Gingival Diseases in 239 participants. Completed in 8 May 2017.
8 May 2017
Quick facts
| Lead sponsor | Unilever R&D |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 239 |
| Start date | 19 October 2016 |
| Primary completion | 8 May 2017 |
| Estimated completion | 8 May 2017 |
Drugs / interventions tested
- Fluoride Toothpaste 1
- Fluoride Toothpaste 2
Conditions studied
- Gingival Diseases — all drugs for Gingival Diseases →
Sponsor
Unilever R&D — full company profile →
Who can join
18 and older, any sex, with Gingival Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a double-blind, randomised, parallel group efficacy study. A minimum of 240 healthy female and male participants aged over 18 years will participate. The participants will be randomised into two groups. Participants will be randomly assigned to the test groups according the allocation table prepared by the Statistician. Participants will be enrolled on to the study according to the inclusion/exclusion criteria. After enrollment participants will have their teeth cleaned using a professional prophylaxis polish by the study hygienist. The participants will then be provided with a standard cosmetic silica fluoride toothpaste and a toothbrush to use at home, twice a day for up to four weeks. After this time, they will return to the test site and have the baseline dental assessments. Participants will then be randomly allocated to one of the two test products which they will use at home, twice a day for the duration of the study. Dental assessments will be conducted after 13 and 26 weeks of product use at the study site.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03027908
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gingival Diseases
Currently open trials in the same condition.
- NCT07104019 — Biofiller and Gingival Phenotype Thickening · NA · recruiting
- NCT06490679 — Evaluation Of Nonsurgical Treatment Of Deep Periodontal Pockets (7-10mm) Using AIRFLOW® Prophylaxis Master Device With E · NA · recruiting
- NCT06351982 — Treatment Of Shallow Periodontal Pockets 4-6mm Using AIRFLOW Prophylaxis Master Device With Erythritol vs Manual Scalers · NA · recruiting
- NCT05759780 — OCT Vibrography for Biomechanical Properties of Tissues · NA · recruiting
- NCT07536204 — Characterization of JAK1 and JAK2 Activation in Gingival Tissues During Homeostasis and Periodontitis · recruiting
Other Unilever R&D trials
Trials by the same sponsor.
- NCT06640244 — The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening · NA · completed
- NCT06413810 — The Effects of a Food Ingredient on Self-reported Stress · NA · completed
- NCT05013801 — A Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate Melasma · NA · completed
- NCT04155658 — Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation · NA · completed
- NCT03953391 — The Effect of Tea Breaks on Cerebrovascular Perfusion During Desk Work · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03027908 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unilever R&D
- Last refreshed: 7 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03027908.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing